Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin

被引:46
作者
Pal, S [1 ]
Bhattacharyya, S [1 ]
Choudhuri, T [1 ]
Datta, GK [1 ]
Das, T [1 ]
Sa, G [1 ]
机构
[1] Bose Inst, Kolkata 700054, W Bengal, India
来源
CANCER DETECTION AND PREVENTION | 2005年 / 29卷 / 05期
关键词
anti-oxidant; curcumin; detoxification; immunodepletion; tumor; immunosupression; oxidative stress; anti-cancer drugs; superoxide dismutase; glutathione-S-transferase; glutamate oxaloacetate transaminase; cell cycle phase; enzyme assay; biotransformation enzymes; lymphocyte apoptosis; tumor burden; Ehrlich's ascites carcinoma;
D O I
10.1016/j.cdp.2005.05.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The true therapeutic benefit of the use of natural products, especially acceptable dietary components such as curcumin, which can spare the normal cells and boost host immunity, has opened new horizons in cancer prevention and treatment. Methods: In our model system we used Ehrlich's ascites carcinoma cells grown in peritoneal carity of Swiss albino mice and curcumin was fed every alternative day. Results: Here, we report that curcumin administration to tumor-bearing mice decreased tumor cell number significantly in a dose-dependent manner Furthermore, tumor-induced depletion of immune cell number of the host, as was evidenced from the decrease in bone marrow progenitor as well as thymic and splenic mononuclear cell numbers, was reintrated by curcumin. In fact, curcumin inhibited tumor-induced apoptosis of both thymocytes and splenocytes thereby restoring immune cell numbers to normal level in treated Ehrlich's ascites carcinoma-bearing mice. Moreover, curcumin was not toxic to the host; rather in tumor-bearing mice it inhibited hematopoietic toxicity, acted as a hepato protective agent and activated depressed anti-oxidant and detoxification systems. Conclusion: The ability of curcumin to regress tumor as well as to protect the host from tumor-induced immunosuppression and toxicity strongly supports the candidacy of curcumin as a potential agent for the dietary therapy of cancer. (c) 2005 International Society for Preventive Oncology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:470 / 478
页数:9
相关论文
共 46 条
[1]   PHARMACOLOGY OF CURCUMA-LONGA [J].
AMMON, HPT ;
WAHL, MA .
PLANTA MEDICA, 1991, 57 (01) :1-7
[2]   Immunomodulatory activity of curcumin [J].
Antony, S ;
Kuttan, R ;
Kuttan, G .
IMMUNOLOGICAL INVESTIGATIONS, 1999, 28 (5-6) :291-303
[3]  
Bergan RC, 1999, CLIN CANCER RES, V5, P2366
[4]   Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor [J].
Berlin, J ;
Tutsch, KD ;
Hutson, P ;
Cleary, J ;
Rago, RP ;
Arzoomanian, RZ ;
Alberti, D ;
Feierabend, C ;
Wilding, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :781-789
[5]   OXYRADICALS AND CANCER [J].
CERUTTI, PA .
LANCET, 1994, 344 (8926) :862-863
[6]   The host-tumor immune conflict: from immunosuppression to resistance and destruction [J].
Chouaib, S ;
AsselinPaturel, C ;
MamiChouaib, F ;
Caignard, A ;
Blay, JY .
IMMUNOLOGY TODAY, 1997, 18 (10) :493-497
[7]   Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction [J].
Choudhuri, T ;
Pal, S ;
Agwarwal, ML ;
Das, T ;
Sa, G .
FEBS LETTERS, 2002, 512 (1-3) :334-340
[8]   Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile [J].
Churchill, M ;
Chadburn, A ;
Bilinski, RT ;
Bertagnolli, MM .
JOURNAL OF SURGICAL RESEARCH, 2000, 89 (02) :169-175
[9]   Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells [J].
Ciolino, HP ;
Daschner, PJ ;
Wang, TTY ;
Yeh, GC .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (02) :197-206
[10]  
Conney AH, 1997, P SOC EXP BIOL MED, V216, P234, DOI 10.3181/00379727-216-44173